Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patrick Fleming, MD, Maggie Cheung, MD, David Sokol, MD

Blood (2018) 132 (Supplement 1): 5005.

https://doi.org/10.1182/blood-2018-99-119893

Published: 2018

Journal Articles

Patient with Myeloma Who Develops Thrombotic Microangiopathy without Hemolysis

Juliana Alvarez Argote, MD

Blood (2018) 132 (Supplement 1): 5661.

https://doi.org/10.1182/blood-2018-99-117095

Published: 2018

Journal Articles

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Morie A. Gertz, MD MACP, Haiyan Qiu, PhD, Laura Kendall, Mario Saltarelli, MDPhD, Ted Yednock, PhD, Sethu Sankaranarayanan, PhD

Blood (2016) 128 (22): 1265.

https://doi.org/10.1182/blood.V128.22.1265.1265

Published: 2016

Journal Articles

Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

Bernd Jilma, MD, James C Gilbert, MD, Sandip Panicker, PhD, Graham C Parry, PhD, Michael Fillitz, MD, Schenk Thomas, Christian Sillaber, MD, Johann Bartko, MD, Ulrich Jaeger, MD

Blood (2016) 128 (22): 2435.

https://doi.org/10.1182/blood.V128.22.2435.2435

Published: 2016

Journal Articles

Identification Of Protein and Post Translational Modification Markers Of Pulmonary Vasculopathy In Sickle Cell Disease

Elizabeth S Klings, MD, Stephen Whelan, PhD, Roger Theberge, PhD, Jean L Spencer, PhD, Martin H. Steinberg, MD, Catherine E Costello, PhD, Mark E McComb, PhD

Blood (2013) 122 (21): 2233.

https://doi.org/10.1182/blood.V122.21.2233.2233

Published: 2013

Journal Articles

Cold Hemagglutinin Hemolysis and Hypercoagulable State Due to Mycoplasma Pneumoniae.

Gaurav Gulati, MD, Anthony A Donato, MD, Shuchi Gulati, MD, Daniel A Forman, DO

Blood (2009) 114 (22): 5094.

https://doi.org/10.1182/blood.V114.22.5094.5094

Published: 2009

Journal Articles

Malignant Lymphoma in Primary Sjögren Syndrome: Incidence and Risk Factors.

Andrés López, Roser Solans-Laque, Josep A Bosch-Gil, Mercedes Gironella, Noelia Purroy, Campillo Marta, Teresa Vallespi, MD.PhD..

Blood (2009) 114 (22): 4991.

https://doi.org/10.1182/blood.V114.22.4991.4991

Published: 2009

Journal Articles

Serum Proteomic Profiling and Study of Haptoglobin Polymorphisms in Patients with Chronic GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Joseph P. McGuirk, DO, Ying Yan, MD, Hao Gang, PhD, Weijian Hou, PhD, Sunil Abhyankar, MD, Casey Williams, PharmD, Robert Belt, MD, Jianpa Ruan, MD, Weisi Yan, PhD, Jeffery Wieman, MD

Blood (2006) 108 (11): 2890.

https://doi.org/10.1182/blood.V108.11.2890.2890

Published: 2006

Journal Articles

A Phase I Open Label Dose Escalation Study To Evaluate MEDI-507 in Patients with CD2-Positive T-Cell Lymphoma/Leukemia.

Deborah A. Casale, MS, Nancy L. Bartlett, MD, David D. Hurd, MD, Francine Foss, MD, Barbara Pro, MD, Lubomir Sokol, MD, PhD, Ronald Lieberman, MD, Hammershaimb Luz, MD

Blood (2006) 108 (11): 2727.

https://doi.org/10.1182/blood.V108.11.2727.2727

Published: 2006

Journal Articles

Response to Rituximab in Type II Cryoglobulinemia.

Alan H. Bryce, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Martha Lacy, MD, S. Vincent Rajkumar, MD, David James Inwards, MD, Christopher Yasenchak, MD, Shaji Kumar, MD, Morie Abraham Gertz, MD

Blood (2005) 106 (11): 3499.

https://doi.org/10.1182/blood.V106.11.3499.3499

Published: 2005

Journal Articles

Plasma Protein Concentrations of Complement Components C4 and C3 Are Inversely Associated with Anticardiolipin Antibodies in APS Patients.

Stephanie L. Savelli, MD, Robert A.S. Roubey, MD, Gail S. Buxton, MA, Yan Yang, PhD, Yeeling Wu, BA, BS, C. Yung Yu, D. Phil

Blood (2005) 106 (11): 2645.

https://doi.org/10.1182/blood.V106.11.2645.2645

Published: 2005

NARROW

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patient with Myeloma Who Develops Thrombotic Microangiopathy without Hemolysis

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

Identification Of Protein and Post Translational Modification Markers Of Pulmonary Vasculopathy In Sickle Cell Disease

Cold Hemagglutinin Hemolysis and Hypercoagulable State Due to Mycoplasma Pneumoniae.

Malignant Lymphoma in Primary Sjögren Syndrome: Incidence and Risk Factors.

Serum Proteomic Profiling and Study of Haptoglobin Polymorphisms in Patients with Chronic GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

A Phase I Open Label Dose Escalation Study To Evaluate MEDI-507 in Patients with CD2-Positive T-Cell Lymphoma/Leukemia.

Response to Rituximab in Type II Cryoglobulinemia.

Plasma Protein Concentrations of Complement Components C4 and C3 Are Inversely Associated with Anticardiolipin Antibodies in APS Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only